Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
711 people get THRX articles and Market Currents by email alert.
Get email alerts on THRX »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
Marketwire (May 13, 2013)
-
Marketwire (May 10, 2013)
-
Marketwire (Apr 25, 2013)
-
Marketwire (Apr 23, 2013)
-
Marketwire (Apr 22, 2013)
-
-
Marketwire (Apr 18, 2013)
-
Marketwire (Apr 17, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
Theravance: Buy This Biopharma On WeaknessChris Lau • Mon, Aug 13, 2012
-
Theravance: Vote Of Confidence?The Value Investor • Tue, Apr 3, 2012 -
-
-
Theravance May Be Moving HigherM. E. Garza • Wed, Nov 9, 2011 -
Theravance: Fairly Balanced Risk / Reward ProfileZacks Investment Research • Thu, Dec 30, 2010 -
-
Theravance Narrows Its LossesZacks Investment Research • Fri, Apr 24, 2009
-
FDA Sets Date for Theravance Drug ReviewBrett Scott • Fri, Jan 11, 2008
-
-
-
-
-
-
-
-
-
-
-
-
Seth Klarman's Top Stock PicksInsider Monkey • Wed, Feb 20
-
-
-
-
-
-
Tracking Seth Klarman's Baupost Group Holdings - Q3 2012 UpdateJohn Vincent • Wed, Nov 14, 2012
-
-
For NovaBay, Simplicity Is The Father Of InventionRyan's View • Mon, Nov 12, 2012
-
Theravance's CEO Discusses Q3 2012 Results - Earnings Call TranscriptTue, Oct 30, 2012 • 1 Comment
-
Theravance Inc. CEO Discusses Q3 2010 Results - Earnings Call TranscriptThu, Oct 21, 2010
-
Theravance Inc Q2 2010 Earnings Call TranscriptThu, Jul 22, 2010
-
Theravance Inc. Q1 2010 Earnings Call TranscriptWed, Apr 21, 2010
-
Theravance, Inc. Q3 2009 Earnings Call TranscriptTue, Oct 27, 2009
-
Theravance, Inc. Q4 2008 Earnings Call TranscriptThu, Feb 12, 2009
-
Theravance, Inc. Q3 2008 Earnings Call TranscriptWed, Oct 29, 2008
-
Marketwire (May 13, 2013)
-
Marketwire (May 10, 2013)
-
Marketwire (Apr 25, 2013)
-
Marketwire (Apr 23, 2013)
-
Marketwire (Apr 22, 2013)
-
Marketwire (Apr 18, 2013)
-
Marketwire (Apr 17, 2013)
-
Marketwire (Apr 17, 2013)
-
at CNBC.com (Apr 15, 2013)
-
Marketwire (Apr 11, 2013)
-
Marketwire (Feb 21, 2013)
-
Marketwire (Feb 13, 2013)
-
Marketwire (Feb 12, 2013)
-
Marketwire (Jan 31, 2013)
-
Marketwire (Jan 29, 2013)
-
Marketwire (Jan 24, 2013)
THRX vs. ETF Alternatives
Company Description
Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates. We are focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, May 20, 1:37 PM More on Royalty Pharma/ Elan (ELN +3.3%): Royalty says ELN "dramatically overpaid" for its 21% participation interest in future royalty payments from Theravance's (THRX -5.9%) respiratory collaborations with GlaxoSmithKline (GSK +0.2%). The deal was made in a "hasty" fashion Royalty claims, and says the same might well be said of ELN's purchases of AOP Oprhan Pharmaceuticals and a 48% stake in NewBridge Pharmaceuticals (for a combined cost of $380M). The new offer ($12.50/share) is contingent upon shareholders voting against the THRX deal. Comment! [Healthcare, M&A]
- Monday, July 2, 2012, 2:38 PM Piper Jaffray looks at other potential takeout candidates in the biotech space post-Amylin, highlighting BioMarin (BMRN +3.8%), Affymax (AFFY +1%), Theravance (THRX +8.3%), and Rigel Pharmaceuticals (RIGL +2.3%) all as potential candidates. Piper notes that BioMarin could fetch as much as $79 per share, and notes that Japanese drug heavyweight Takeda Pharmaceuticals (TKPYY.PK) could be the most likely suitor for Affymax. Comment! [Healthcare, On the Move, M&A]
- Monday, April 2, 2012, 7:49 AM GlaxoSmithKline (GSK) buys 10M shares of Theravance (THRX) at a price of $21.2887 a pop - taking its stake in the asthma drug firm up to 26.8%. The transaction needs the approval of Theravance's stockholders before closing. Premarket: GSK +0.7%, THRX inactive. Comment! [M&A, On the Move, Healthcare]
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
smokeyRose
on the Filp side I lost a little on $THRX was up now down but i will long this Money maker! - View all 0 replies
-
- View all 0 replies
-
Red Acre Investments
just published part 1 of our April Biotech binary event watch : http://bit.ly/ZmquIg $AGN, $THRX, $ENDP, $SCMP, $GILD - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Skull & Bones
Some kind of BIG news on $THRX looks imminent.......interesting price movement in the shares over the past several days. - View all 0 replies
LATEST REPLIES
-
Scott Matusow
I will be writing about $LGND and others very soon. some other good one out there like $IPXL and $THRX - View all 3 replies
-
-
-
- View all 1 replies
-
